In this Product Explainer, Pain Medicine Physician A/Prof Marc Russo explains the role of Norgesic (orphenadrine + paracetamol) and Norflex (orphenadrine) in the management of muscle spasm.
Despite their long history, rigorous experimental research to test the effectiveness of spinal cord stimulators has only been conducted this century. The findings don’t support their use for treating chronic pain...
Most people with chronic back pain naturally think their pain is caused by injuries or other problems in the body such as arthritis or bulging disks...
What are yellow flags for back pain?, knowing these and practising mindful therapeutics can help mitigate the risk of progression of acute pain to chronic pain, and how chronic pain is a disease in its own right
In this Product Explainer, Pain Management Physician Dr Clayton Thomas explains the role of tapentadol, an atypical opioid, when clinically indicated and key considerations for GPs when choosing an opioid as part of a multi-modal, multi-disciplinary approach to managing severe pain (4 mins).
This article outlines the key changes associated with Active Ingredient Prescribing, the reasons for its introduction and the practicalities in relation to its application in the primary care setting.
Opioids are strong medicines used for pain. The new rules – including reducing pack sizes and restrictions around prescribing – are part of a range of changes planned for prescription opioid medicines to be phased in over the next year or so.